Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1149220080160020133
Korean Journal of Oriental Medical Prescription
2008 Volume.16 No. 2 p.133 ~ p.144
Clinical study of Bangpoongtongsungsan on body weight change in subjects with obesity
Shin Dae-Hee

Cho Guk-Hyun
Lee Hyeok
Moon Mi-Kyung
Kang Dae-Gil
Yun Young-Gab
Park Do-Sim
Juhng Seon-Kwan
Lee Ho-Sub
Abstract
Recently, people are becoming fatter in most parts of the world. Obesity is regarded as an important risk factor to adversely affect the health of humans, associated with hypertension, hyperlipidemia, diabetes, and cardiovascular diseases. In the present study, therefore, we tested the short time efficiency and safety of Bangpoongtongsungsan as a drug to decrease body weight in subjects with obesity. A total 48 volunteers (24 man, 24 woman) with body mass index (BMI : weight in kg divided by square of height in meters) of participated in clinical study for 12 weeks, from 2008, March 01 to 2008, Jun 30. The subjects was received a dietary supplement of 12 pieces hard capsules per day (4 pieces in one, 3 times in a day) during the clinical study. At the end of clinical study, body weight of subjects was significantly decreased from to (p<0.05). Waist circumferences of subjects were reduced to (p<0.05). Also, a BMI of subjects was significantly decreased to (p<0.05). Particularly, a decrease in body weight, waist circumferences, and BMI was more significant in woman than man. But, other biochemical levels including lipid and glucose in plasma had no changes at the end of clinical study. In conclusion, administration of Bangpoongtongsungsan in subjects with high body weight fat could inhibit obesity associated with a decrease in body weight, waist circumferences, and BMI.
KEYWORD
Bangpoongtongsungsan, obesity, clinical study
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)